Daily Recap: Health — 30 October 2026

Health news today centers on how institutions respond to risk: from infectious disease outbreaks and frontline deaths to regulatory action on medicines and consumer tests. At the same time, researchers push to reshape prevention, whether by framing online misogyny as a public-hea...

A major measles outbreak in Pennsylvania’s Amish communities continues to grow, with cases now exceeding 1,350 and five deaths reported. Lancaster County, home to the largest Amish population in the United States, is at the center of what is being described as the country’s worst measles outbreak in decades.

An Ebola doctor in eastern Democratic Republic of Congo has died after contracting the virus while treating patients in Beni. Marie-France Shogogo’s death is announced by Africa CDC, which says she was infected during patient care, underscoring the continuing danger faced by frontline health workers during Ebola outbreaks.

Researchers urge governments to treat the manosphere and online misogyny as a public-health risk rather than only a social or policing issue. Writing in The Lancet, they argue that grievance-driven online networks can harm health and wellbeing at population scale and should be addressed with prevention strategies used for other major public-health threats.

India’s drug regulators have ordered Sun Pharma to stop making eye medicines at a plant in Assam over quality compliance lapses. The move adds to broader scrutiny of manufacturing standards in the country’s pharmaceutical sector and signals tougher enforcement around the safety of medicines supplied from domestic factories.

A UK clinical trial is testing whether breast cancer radiotherapy can be reduced from a three-week schedule to just five days without sacrificing safety or effectiveness. The study spans 39 hospitals and aims to find out whether shorter treatment can deliver comparable outcomes while cutting the burden of repeated hospital visits.

A UK consumer watchdog warns that at-home vitamin D test kits may give unreliable results. Independent checks find significant differences between readings from self-use kits and standard laboratory blood tests, raising concerns that people could be falsely reassured or unnecessarily alarmed when checking their vitamin D levels at home.

A UCL review finds there is not enough evidence to say whether testosterone helps menopausal brain fog or memory problems. The study examines cognitive symptoms in midlife women and concludes that current data are too limited to determine whether the hormone improves thinking and memory during menopause.

Creatine is drawing growing interest from researchers studying whether it may have mental health benefits beyond its established use as a fitness supplement. The idea is that by affecting the brain’s energy systems, creatine could influence mood and wellbeing, but the evidence remains an emerging area rather than settled practice.